Why Globus Medical Missed Q1 Estimates

Yes, it's been a rough year for Globus Medical (NYSE: GMED). The medical-device stock is down nearly 20% year to date, a steeper decline than the major market indexes. 

But quarterly earnings releases give companies an opportunity to change the narrative. Globus announced its first-quarter results after the market closed on Thursday. This time, though, investors' perceptions probably weren't changed. Here are the highlights from the company's Q1 update.

Image source: Getty Images.

Continue reading

Source Fool.com